CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2012	Dec. 31, 2011
Current Assets
Cash and cash equivalents	$ 21,771,389	$ 12,642,147
Accounts receivable trade, net of allowance for doubtful accounts of $630,707 and $501,841, respectively	10,438,972	6,536,176
Inventory	17,982,323	17,153,396
Deferred income taxes	628,499	463,689
Prepaids and other current assets	2,154,614	1,427,328
Assets related to discontinued operations		1,793,457
Total current assets	52,975,797	40,016,193
Property, plant and equipment, net	47,327,890	48,106,439
Land use rights, net	4,875,876	4,872,444
Goodwill	19,666,460	19,613,470
Intangible assets, net	36,273,850	36,932,431
Other assets	6,164,428	5,786,803
Assets, Total	167,284,301	155,327,780
Current Liabilities
Accounts payable	19,395,210	10,237,524
Accrued liabilities	3,430,310	2,796,018
Bank loans	15,810,000	15,712,000
Notes payable	254,387	148,062
Mortgages payable	3,582,072	3,635,061
Income taxes payable	1,073,313	621,553
Deferred income taxes	655,125	651,064
Unearned revenues	2,934,966	2,436,532
Liabilities related to discontinued operations		208,830
Total current liabilities	47,135,383	36,446,644
Long-term Liabilities
Deferred income taxes	9,171,633	9,300,945
Unearned revenues	156,466	169,198
Notes payable	50,775
Derivative liabilities	387,172	474,463
Acquisition-related contingent consideration	3,130,000	3,130,000
Amount due related parties	21,293,056	20,862,686
Total long-term liabilities	34,189,102	33,937,292
Commitments and Contingencies
Redeemable Securities
Convertible Redeemable Series E Preferred Stock; 10,582,011 shares designated, liquidation value $1.00 per share; issued and outstanding 5,486,969 and 6,662,748 shares, at March 31, 2012 and December 31, 2011, respectively	4,182,482	4,811,326
Temporary Equity, Carrying Amount, Total	4,182,482	4,811,326
Shareholders' Equity
Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at March 31, 2012 and December 31, 2011	100	100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 129,887,148 and 109,329,587 shares, at March 31, 2012 and December 31, 2011, respectively	129,887	109,330
Additional paid-in capital	211,635,762	200,858,638
Accumulated deficit	(152,550,831)	(143,094,854)
Accumulated other comprehensive income	4,156,186	4,152,343
Total NeoStem, Inc. shareholders' equity	63,371,104	62,025,557
Noncontrolling interests	18,406,230	18,106,961
Total equity	81,777,334	80,132,518
Liabilities and Equity, Total	$ 167,284,301	$ 155,327,780